Language: English
Keywords: blocked, website, access, fiercepharma.com, red cross
Layout: Centered text and cross on a white background
ColorStyle: White, gray, red
Overview: This website appears to be a blocked page, displaying a message that reads 'Sorry, you have been blocked. You are unable to access fiercepharma.com'. There is no visible content on the page, just a plain white background with a red cross indicating a blockage. The layout is simple, with the text and cross centered on the page. The color scheme consists of white, gray, and red.
fiercepharma.com was registered 1 decade 7 years ago. It has a alexa rank of #77,881 in the world. Its bounce rate is 70.50%. There are about 1.50 page views per visit. It is a domain having .com extension. It is estimated worth of $ 194,400.00 and have a daily income of around $ 270.00. As no active threats were reported recently, fiercepharma.com is SAFE to browse.
Daily Unique Visitors: | 22,515 |
Daily Pageviews: | 135,090 |
Income Per Day: | $ 270.00 |
Estimated Worth: | $ 194,400.00 |
Google Indexed Pages: | Not Applicable |
Yahoo Indexed Pages: | 187,000 |
Bing Indexed Pages: | 65,900 |
Google Backlinks: | Not Applicable |
Bing Backlinks: | 579,000 |
Alexa BackLinks: | Not Applicable |
Google Safe Browsing: | No Risk Issues |
Siteadvisor Rating: | Not Applicable |
WOT Trustworthiness: |
![]() |
WOT Privacy: |
![]() |
WOT Child Safety: |
![]() |
Alexa Rank: | 77,881 |
PageSpeed Score: | 53 ON 100 |
Domain Authority: |
49 ON 100 ![]() |
Bounce Rate: | 70.50% |
Time On Site: | 2:18 |
Total Traffic: | 558.48K |
Direct Traffic: | 27.32% |
Referral Traffic: | 11.78% |
Search Traffic: | 48.95% |
Social Traffic: | 5.70% |
Mail Traffic: | 6.25% |
Display Traffic: | 0% |
Visit FiercePharma for pharma industry news on big pharma, FDA decisions, patents, pharmaceutical marketing, generic drugs, and other pharma news.
Oct 16, 2020 · The World Health Organization is raising doubts about the rapid emergency authorization of Gilead Sciences' antiviral remdesivir for treating COVID-19. A large...
We would like to show you a description here but the site won’t allow us.
FiercePharma is the pharma industry's daily monitor, with a special focus on pharmaceutical company news and the market development of FDA approved products. Our free, daily...
Fiercepharma.com Website Analysis (Review) Fiercepharma.com has 12,021 daily visitors and has the potential to earn up to 1,443 USD per month by showing ads. See traffic...
Reddit gives you the best of the internet in one place. Get a constantly updating feed of breaking news, fun stories, pics, memes, and videos just for you. Passionate about...
Whois Lookup for fiercepharma.com
Provided by Alexa ranking, fiercepharma.com has ranked 15494th in United States and 37,913 on the world.fiercepharma.com reaches roughly 84,804 users per day and delivers about...
Apr 06, 2020 · Vir Biotechnology is adding GlaxoSmithKline to its roster of COVID-19 partners—and snagging a $250 million investment in the process. The duo will pool their...
H1 Headings: | Not Applicable | H2 Headings: | 13 |
H3 Headings: | 5 | H4 Headings: | 1 |
H5 Headings: | Not Applicable | H6 Headings: | Not Applicable |
Total IFRAMEs: | 1 | Total Images: | 18 |
Google Adsense: | Not Applicable | Google Analytics: | Not Applicable |
Domain Registrar: |
NameCheap, Inc.
![]() |
---|---|
Registration Date: | 2007-05-18 1 decade 7 years 10 months ago |
Last Modified: | 2019-04-17 5 years 11 months 3 weeks ago |
Host | IP Address | Country | |
---|---|---|---|
hans.ns.cloudflare.com | ![]() |
108.162.193.175 | ![]() |
melissa.ns.cloudflare.com | ![]() |
173.245.58.199 | ![]() |
Host | Type | TTL | Extra |
---|---|---|---|
fiercepharma.com | A | 287 |
IP: 104.16.120.85 |
fiercepharma.com | A | 287 |
IP: 104.16.119.85 |
fiercepharma.com | NS | 86400 |
Target: hans.ns.cloudflare.com |
fiercepharma.com | NS | 86400 |
Target: melissa.ns.cloudflare.com |
fiercepharma.com | SOA | 3600 |
MNAME: hans.ns.cloudflare.com RNAME: dns.cloudflare.com Serial: 2030859538 Refresh: 10000 Retry: 2400 Expire: 604800 |
fiercepharma.com | MX | 300 |
Target: fiercepharma-com.mail.protection.outlook.com |
fiercepharma.com | TXT | 300 |
TXT: MS=ms87603847 |
fiercepharma.com | TXT | 300 |
TXT: v=spf1 ip4:208.95.132.73 ip4:208.66.206.23 mx a:fiercemarkets.com include:mktomail.com include:spf.protection.outlook.com -all |
fiercepharma.com | TXT | 300 |
TXT: google-site-verification=I7GwycFm_rRBvtk 7t6M53A9hzPBh8X2m-AAv1ujmDmA |
Country Name | Percent Traffic | Rank In Country |
---|---|---|
United States | 64.9% | 19,301 |
United Kingdom | 4.9% | 41,581 |
India | 4.4% | 67,815 |
South Korea | 2.5% | 29,216 |
Germany | 2.4% | 98,954 |
1. valsartan recall | 3.09% |
2. pfizer 100 drugs | 3.02% |
3. merck | 1.73% |
4. fiercepharma | 1.14% |
5. fierce pharma | 1.04% |
fiercepharma.com | 100.00% |
1. | fiercepharma |
2. | fierce pharma |
3. | abbvie |
4. | skyrizi |
5. | bristol myers squibb |
1. | merck mind control |
2. | the reason that cascade merger sub inc. ("purchaser"), a wholly owned subsidiary of merck sharp |
3. | pharma nectar |
4. | organizer of women in life science symposium |
1. | go.questexweb.com |
2. | fiercebiotech.com |
3. | finanznachrichten.de |
4. | feedly.com |
5. | beursig.com |
1. | pages.questexweb.com |
2. | fiercebiotech.com |
3. | astrazeneca.com |
4. | addtoany.com |
5. | oxfamamerica.org |
Site | Url |
---|---|
sina.com.cn | http://blog.sina.com.cn/s/blog_59834aba0102xe9i.html |
naver.com | http://m.blog.naver.com/bonita_o/220939786656 |
fc2.com | http://pharmaip.blog.fc2.com/blog-category-6.html |
businessinsider.com | http://uk.businessinsider.com/most-valuable-substances-by-weight-2014-9 |
nature.com | http://blogs.nature.com/spoonful/2010/03/the_daily_dose_life_expectancy.html |
I/O 3000は、Webデザインに関わる人のためのWebデザインギャラリーサイトです。国内外を問わず、Web制作の参考となるサイトをセレクトしています。
Easy Surveys - Surveys for everyone, you will have the opportunity to be rewarded by filling out the best surveys
Weave's software helps boost revenue and save time by simplifying communication. Learn how Weave's complete business toolbox can enhance your customer communication process.